10/31/2024
4:14 PM | Abbott Laboratories (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
4:10 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
6:37 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
4:27 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:33 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:39 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:48 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/13/2024
4:24 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:20 PM | Abbott Laboratories (Subject)
Ford Robert B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
7:03 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
6:52 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:02 PM | Abbott Laboratories (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024
6:37 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:39 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:30 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
4:35 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:59 PM | Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024
3:02 PM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
5:05 PM | Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:11 PM | Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:16 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:22 PM | Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:29 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
4:54 PM | Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
5:00 PM | Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
4:43 PM | Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
4:48 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
4:33 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
4:38 PM | Abbott Laboratories (Issuer)
Babineaux-Fontenot Claire (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
6:36 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
5:50 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:58 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:32 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:40 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:09 PM | Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:14 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:18 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:22 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:56 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:00 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:05 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
03/04/2024
5:39 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:44 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:50 PM | Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:53 PM | Abbott Laboratories (Subject)
Salvadori Daniel Gesua Sive (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:39 PM | Abbott Laboratories (Subject)
Moreland Mary K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:45 PM | Abbott Laboratories (Subject)
Morrone Louis H. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:22 PM | Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:25 PM | Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:32 PM | Abbott Laboratories (Subject)
MCCOY JOHN A. JR. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:13 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:45 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:35 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:38 PM | Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:40 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:43 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:27 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:29 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:33 PM | Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:23 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:03 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:15 PM | Abbott Laboratories (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/31/2024
4:30 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:04 PM | Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
6:36 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:38 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:28 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:30 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:33 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
4:36 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
